Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

377
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
377
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

315
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
315
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Design of the OverCool study: Lung-conservative liquid ventilation for the induction of Ultra-Rapid Cooling after Cardiac Arrest (OverCool).

Resuscitation plus·2025
Same author

Association of age with extubation failure in neurocritical intensive care unit patients--Insight from an international prospective study named ENIO.

Journal of critical care·2025
Same author

A consensus of European experts on the definition of ventilator-associated pneumonia recurrences obtained by the Delphi method: the RECUVAP study.

Intensive care medicine·2025
Same author

Recovery Potential in Patients After Cardiac Arrest Who Die After Limitations or Withdrawal of Life Support.

JAMA network open·2025
Same author

Alterations in the renin-angiotensin system during septic shock.

Annals of intensive care·2025
Same author

Management of severe acute encephalopathy in the ICU: an expert consensus statement from the french society of intensive care medicine.

Annals of intensive care·2025
Same journal

Mouse models to study von Willebrand factor in inflammation: a scoping review.

Intensive care medicine experimental·2026
Same journal

Confocal laser endomicroscopy in patients with acute respiratory failure.

Intensive care medicine experimental·2026
Same journal

Source-controlled bacterial peritonitis improves survival but leaves persistent lung inflammation and airway IgA loss.

Intensive care medicine experimental·2026
Same journal

Noradrenaline-trajectory phenotypes in septic shock: derivation and external validation in two independent cohorts.

Intensive care medicine experimental·2026
Same journal

Exploratory dose modeling of hemoadsorption in pediatric septic shock.

Intensive care medicine experimental·2026
Same journal

Sex-related differences in lung injury distribution and outcomes in COVID-19 acute respiratory failure: insights from the CT-COVID19 multicenter study group.

Intensive care medicine experimental·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

18.4K

ドブタミンの投与:標準化されたアプローチの提案

Lorenzo Calabró1, Filippo Annoni2, Fabio Silvio Taccone2

  • 1Department of Intensive Care, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles, 1070, Brussels, Belgium. l.calabro@hubruxelles.be.

Intensive care medicine experimental
|August 31, 2025
PubMed
まとめ
この要約は機械生成です。

この研究は,重症患者のドブタミン,イノトロプ剤の使用の枠組みを提案しています. 明確な指示と継続的なモニタリングを強調し,心臓の収縮性を最適化し,患者の結果を改善します.

キーワード:
心臓の出力ドブタミンヘモダイナミックモニタリング臓器機能障害ショック組織浸透

さらに関連する動画

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

3.7K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

関連する実験動画

Last Updated: Sep 9, 2025

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

18.4K
Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

3.7K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

科学分野:

  • クリティカル ケア 医療
  • 心臓病科
  • 薬理学について

背景:

  • ドブタミンは,心臓の収縮能力が低下した重症患者の一般的なイノトロピック剤です.
  • リスクと利益の関係が議論されており,その使用に関する構造的なガイドラインは欠けています.

研究 の 目的:

  • ドブタミンを臨床および実験環境で投与するための実用的な枠組みを提案する.
  • 低心電量症候群 (LCOS) を含む心臓発作性ショック,セプティックショックにおけるドブタミンの合理的かつ一貫した使用を保証する.

主な方法:

  • ドブタミンは急性循環不全と低血流および心収縮の障害のために処方されるべきであり,低心指数だけでは不十分である.
  • エコカルジオグラフィーは初期評価に不可欠であり,投与量反応の評価のために継続的な心臓出力モニタリングによって補完されます.
  • 標準化されたアプローチでは,心臓指数と輸血マーカーに基づいて20分ごとに段階的に定位する2.5μg/ kg/ minの開始用量が含まれています.

主要な成果:

  • ドブタミンの投与量のエスカレーションは,心指数の有意な増加と低血流の解消によって導かれます.
  • 心臓指数が改善したにもかかわらず,持続的な低血流は不十分な反応を示し,慎重に投与量を増加させる必要があります.
  • 心臓指数がさらに上昇する継続的な低血流は,フロー独立の赤字を示し,さらなる定位を阻害します.

結論:

  • ドブタミンの使用には,明確な指示と,継続的な血液動力学と perfusion 監視を統合した標準化されたアプローチが必要です.
  • この戦略は,不必要な曝露と有害な影響を最小限に抑えながら,治療効果を最適化することを目的としています.
  • 提案された枠組みは,集中治療における合理的で再現可能なイノトロピック治療を促進します.